These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 22533855)

  • 1. Absence of association between ex vivo susceptibility to doxycycline and pftetQ and pfmdt copy numbers in Plasmodium falciparum isolates from Dakar, Senegal.
    Gaillard T; Fall B; Tall A; Wurtz N; Diatta B; Lavina M; Fall KB; Sarr FD; Baret E; Diémé Y; Wade B; Bercion R; Briolant S; Pradines B
    Clin Microbiol Infect; 2012 Jul; 18(7):E238-40. PubMed ID: 22533855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PftetQ and pfmdt copy numbers as predictive molecular markers of decreased ex vivo doxycycline susceptibility in imported Plasmodium falciparum malaria.
    Gaillard T; Briolant S; Houzé S; Baragatti M; Wurtz N; Hubert V; Lavina M; Pascual A; Travaillé C; Le Bras J; Pradines B;
    Malar J; 2013 Nov; 12():414. PubMed ID: 24225377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of correlation between ex vivo susceptibility to doxycycline and pfteQ-pfmdt gene polymorphism in French Guiana.
    Mura M; Briolant S; Donato D; Volney B; Pelleau S; Musset L; Legrand E
    Malar J; 2015 Jul; 14():286. PubMed ID: 26206143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility of Plasmodium falciparum isolates to doxycycline is associated with pftetQ sequence polymorphisms and pftetQ and pfmdt copy numbers.
    Briolant S; Wurtz N; Zettor A; Rogier C; Pradines B
    J Infect Dis; 2010 Jan; 201(1):153-9. PubMed ID: 19929377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced in vitro doxycycline susceptibility in plasmodium falciparum field isolates from Kenya is associated with PfTetQ KYNNNN sequence polymorphism.
    Achieng AO; Ingasia LA; Juma DW; Cheruiyot AC; Okudo CA; Yeda RA; Cheruiyot J; Akala HM; Johnson J; Andangalu B; Eyase F; Jura WG; Kamau E
    Antimicrob Agents Chemother; 2014 Oct; 58(10):5894-9. PubMed ID: 25070109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Markers and In Vitro Susceptibility to Doxycycline in Plasmodium falciparum Isolates from Thailand.
    Gaillard T; Sriprawat K; Briolant S; Wangsing C; Wurtz N; Baragatti M; Lavina M; Pascual A; Nosten F; Pradines B
    Antimicrob Agents Chemother; 2015 Aug; 59(8):5080-3. PubMed ID: 26055380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of iron-binding compounds against Senegalese isolates of Plasmodium falciparum.
    Pradines B; Tall A; Ramiandrasoa F; Spiegel A; Sokhna C; Fusai T; Mosnier J; Daries W; Trape JF; Kunesch G; Parzy D; Rogier C
    J Antimicrob Chemother; 2006 Jun; 57(6):1093-9. PubMed ID: 16595639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urban malaria in Dakar, Senegal: chemosusceptibility and genetic diversity of Plasmodium falciparum isolates.
    Henry M; Diallo I; Bordes J; Ka S; Pradines B; Diatta B; M'Baye PS; Sane M; Thiam M; Gueye PM; Wade B; Touze JE; Debonne JM; Rogier C; Fusai T
    Am J Trop Med Hyg; 2006 Jul; 75(1):146-51. PubMed ID: 16837722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limited polymorphisms in k13 gene in Plasmodium falciparum isolates from Dakar, Senegal in 2012-2013.
    Torrentino-Madamet M; Fall B; Benoit N; Camara C; Amalvict R; Fall M; Dionne P; Ba Fall K; Nakoulima A; Diatta B; Diemé Y; Ménard D; Wade B; Pradines B
    Malar J; 2014 Dec; 13():472. PubMed ID: 25471113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of association between Plasmodium falciparum small sub-unit ribosomal RNA gene mutations and in vitro decreased susceptibility to doxycycline.
    Gaillard T; Wurtz N; Houzé S; Sriprawat K; Wangsing C; Hubert V; Lebras J; Nosten F; Briolant S; Pradines B;
    Malar J; 2015 Sep; 14():348. PubMed ID: 26377329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmodium falciparum In Vitro Resistance to Monodesethylamodiaquine, Dakar, Senegal, 2014.
    Fall B; Madamet M; Camara C; Amalvict R; Fall M; Nakoulima A; Diatta B; Diémé Y; Wade B; Pradines B
    Emerg Infect Dis; 2016 May; 22(5):841-5. PubMed ID: 27088703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring of in vitro susceptibilities and molecular markers of resistance of Plasmodium falciparum isolates from Thai-Myanmar border to chloroquine, quinine, mefloquine and artesunate.
    Chaijaroenkul W; Wisedpanichkij R; Na-Bangchang K
    Acta Trop; 2010 Feb; 113(2):190-4. PubMed ID: 19879850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid detection of point mutations in Plasmodium falciparum genes associated with antimalarial drugs resistance by using High-Resolution Melting analysis.
    Andriantsoanirina V; Lascombes V; Ratsimbasoa A; Bouchier C; Hoffman J; Tichit M; Rabarijaona LP; Durand R; Ménard D
    J Microbiol Methods; 2009 Aug; 78(2):165-70. PubMed ID: 19465064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro susceptibility to quinine and microsatellite variations of the Plasmodium falciparum Na+/H+ exchanger transporter (Pfnhe-1) gene in 393 isolates from Dakar, Senegal.
    Pascual A; Fall B; Wurtz N; Fall M; Camara C; Nakoulima A; Baret E; Diatta B; Fall KB; Mbaye PS; Diémé Y; Bercion R; Bogreau H; Briolant S; Rogier C; Wade B; Pradines B
    Malar J; 2013 Jun; 12():189. PubMed ID: 23758769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ex vivo susceptibility of Plasmodium falciparum isolates from Dakar, Senegal, to seven standard anti-malarial drugs.
    Fall B; Diawara S; Sow K; Baret E; Diatta B; Fall KB; Mbaye PS; Fall F; Diémé Y; Rogier C; Wade B; Bercion R; Pradines B
    Malar J; 2011 Oct; 10():310. PubMed ID: 22014157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of Plasmodium falciparum in vitro drug resistance phenotype following culture adaptation compared to fresh clinical isolates in Cambodia.
    Chaorattanakawee S; Lanteri CA; Sundrakes S; Yingyuen K; Gosi P; Chanarat N; Wongarunkochakorn S; Buathong N; Chann S; Kuntawunginn W; Arsanok M; Lin JT; Juliano JJ; Tyner SD; Char M; Lon C; Saunders DL
    Malar J; 2015 Dec; 14():486. PubMed ID: 26626127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the drug susceptibility of Plasmodium falciparum clinical isolates from africa by using a Plasmodium lactate dehydrogenase immunodetection assay and an inhibitory maximum effect model for precise measurement of the 50-percent inhibitory concentration.
    Kaddouri H; Nakache S; Houzé S; Mentré F; Le Bras J
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3343-9. PubMed ID: 17005815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmodium falciparum from Pará state (Brazil) shows satisfactory in vitro response to artemisinin derivatives and absence of the S769N mutation in the SERCA-type PfATPase6.
    Ferreira ID; Martinelli A; Rodrigues LA; do Carmo EL; do Rosário VE; Póvoa MM; Cravo P
    Trop Med Int Health; 2008 Feb; 13(2):199-207. PubMed ID: 18304266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug susceptibility of Plasmodium falciparum from polyclonal isolates].
    Kaddouri H; Jafari S; Durand R; Le Bras J
    J Soc Biol; 2004; 198(3):199-206. PubMed ID: 15662936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergy of mefloquine activity with atorvastatin, but not chloroquine and monodesethylamodiaquine, and association with the pfmdr1 gene.
    Wurtz N; Briolant S; Gil M; Parquet V; Henry M; Baret E; Amalvict R; Almeras L; Rogier C; Pradines B
    J Antimicrob Chemother; 2010 Jul; 65(7):1387-94. PubMed ID: 20501488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.